Systemic antibiotics also contribute a huge deal to the management of bisphosphonate-related osteonecrosis of the jaw. Moreover, Systemic or topical antifungals can be used to deal with this dysfunction. Finally the discontinuation of bisphosphonate therapy which means there will be no dental therapy, meaning the patient would have to resort to a root canal therapy instead of
Systemic antibiotics also contribute a huge deal to the management of bisphosphonate-related osteonecrosis of the jaw. Moreover, Systemic or topical antifungals can be used to deal with this dysfunction. Finally the discontinuation of bisphosphonate therapy which means there will be no dental therapy, meaning the patient would have to resort to a root canal therapy instead of